ArticleFrontiers in endocrinology2022

Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study.

Fukashi Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.